ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: House Members Not Told They were Voting Anti-Impoundment Feature Into Cancer Bill

July 19, 1974

NIH Revises K Series Awards; RFP Available; Program Announcement

June 9, 1995

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

Utah, Hopkins Get Large Donations To Support Research

October 6, 1995

In Brief: HHS Rejects Sole Source Award For Utah Study; Reagan Proclaims April Cancer Control Month

April 3, 1981